Want to join the conversation?
In 1Q16, $PEP's operations outside of the U.S. generated 34% of net revenue, with Mexico, Canada, Russia, the U.K. and Brazil comprising about 15% of net revenue. Unfavorable FX negatively impacted net revenue performance by 4.5 points, primarily due to the Mexican peso, Brazilian real, Russian ruble, Canadian dollar and the Argentine peso.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.